Cynata Therapeutics Ltd (CYP) Company Profile

Cynata Therapeutics Ltd Company Snapshot

Cynata Therapeutics Ltd operates in the Commercial physical research sector. In addition to historical fundamental analyses, the complete report available to purchase compares Cynata Therapeutics Ltd with three other companies in this sector in Australia: Antisense Therapeutics Limited (2017 sales of 140,169.00 Australian Dollars [US$109,080.92 ] ), Vectus Biosystems Ltd (48,841.00 Australian Dollars [US$38,008.55 ] ), and CropLogic Ltd (125,452.88 Australian Dollars [US$97,628.69 ] ).

Sales Analysis.

Cynata Therapeutics Ltd

Stock Data:

Recent Stock Performance:

Current Price (4/20/2018): 1.40
(Figures in Australian Dollars)

1 Week	1.4%	13 Weeks	3.3%

4 Weeks	137.3%	52 Weeks	191.7%

Cynata Therapeutics Ltd Key Data:

Ticker:	CYP	Country:	Australia

Exchanges:		Major Industry:	Commercial Services & Supplies

		Sub Industry:	Commercial Physical Research

2017 Sales	94,231 (Year Ending Jan 2018).	Employees:	N/A

Currency:	Australian Dollars	Market Cap:	126,080,147

Fiscal Yr Ends:	June	Shares Outstanding:	90,057,248

Share Type:	Units	Closely Held Shares:	21,479,022

Feedback | Terms and Conditions | Privacy Policy | Site Index

CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.